April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Altered mTOR Signaling in Senescent Retinal Pigment Epithelium
Author Affiliations & Notes
  • Y. Chen
    Ophthalmology, Vanderbilt Univ Med Ctr, Nashville, Tennessee
  • J. Cai
    Ophthalmology, Vanderbilt Univ Med Ctr, Nashville, Tennessee
  • P. Sternberg, Jr.
    Ophthalmology, Vanderbilt Univ Med Ctr, Nashville, Tennessee
  • Footnotes
    Commercial Relationships  Y. Chen, None; J. Cai, None; P. Sternberg, Jr., None.
  • Footnotes
    Support  Supported by a Postdoctoral Scholar Award from International Retina Research Foundation, NIH grant EY07892, EY08126 and Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6173. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Chen, J. Cai, P. Sternberg, Jr.; Altered mTOR Signaling in Senescent Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6173.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Mammalian target of rapamycin (mTOR)-mediated signaling network is a central pathway controlling the process of aging, which is a well-defined risk factor of degenerative diseases such as atrophic age-related macular degeneration (AMD). The purposes of this study were to characterize the changes in mTOR pathway in senescent human retinal pigmental epithelium (RPE) cells.

Methods: : Replicative senescence and post-confluent culture of primary human fetal RPE cells were used to induce in vitro aging. Senescence of the RPE was assessed by measuring the population doubling time, the activity of senescence associated β-galactosidase and the expression level of p16, a cyclin-dependent kinase inhibitor. Immortalized ARPE-19 cell line was used as a negative control for the study. Activation of mTOR complex I (mTORC1) was measured by the phosphorylation status of its downstream substrate S6.

Results: : The mTORC1 in RPE cells can be activated by nutrient and growth factor stimuli. Increased phosphorylation of S6 in response to amino acid was observed in aged RPE cells in two independent models of in vitro aging. Rapamycin, the prototypic mTOR inhibitor, inhibited the senescent phenotype of cultured human RPE cells.

Conclusions: : RPE cells have functional mTOR signaling network. Delaying aging of the RPE by regulating mTOR signaling can be a potential therapeutic option for degenerative changes associated with atrophic AMD.

Keywords: age-related macular degeneration • aging • signal transduction 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.